ACRS - Aclaris Therapeutics Stock Trading

Aclaris Therapeutics Inc.(NASDAQ: ACRS) stock trading, description, contact, officers and directors.

About Aclaris Therapeutics Inc.

Aclaris Therapeutics, Inc. is a clinical stage specialty pharmaceutical company focused on identifying, developing and commercializing innovative and differentiated therapies to address significant unmet needs in dermatology

Stock Information

Aclaris Therapeutics Inc. Company Name:

ACRS Stock Symbol:

NASDAQ Market:

Aclaris Therapeutics Inc. Website:

ACRS - Aclaris Therapeutics Stock Trading

ACRS ACRS Quote ACRS Short ACRS News ACRS Articles ACRS Message Board

Get ACRS Alerts

News, Short Squeeze, Breakout and More Instantly...

ACRS - Aclaris Therapeutics Completes Enrollment in its Phase 2a Clinical Trial of ATI-1777 for Moderate to Severe Atopic Dermatitis

Enrollment Completed Data Expected Mid-Year 2021 WAYNE, Pa., March 15, 2021 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, tod...
ACRS - Aclaris Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides a Corporate Update

Positive Preliminary Topline Data for ATI-450, an Investigational Oral MK2 Inhibitor, in Moderate to Severe Rheumatoid Arthritis Announced in January 2021 ATI-450 Data Support New Oral Approach for the Potential Treatment of Immuno-inflammatory Diseases, such as Rheumatoid...
ACRS - Aclaris Therapeutics to Participate in Upcoming Investor Conferences

WAYNE, Pa., Feb. 22, 2021 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today announced that Dr. Neal Walker, President and CEO of Aclaris, will present ...